GlassScriptPhysician profile
Adam D Camp
NPI 1518107606
$4,468.59
in general payments reported to CMS, 2019-2025
31 companies · $173 in 2025
The $173 reported for 2025 was more than what 78% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,618 · 2020: $360 · 2021: $318 · 2022: $348 · 2023: $410 · 2024: $242 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,614.39 | 2019 | |
| Abbvie INC. | $482.56 | 2021-2025 | Ubrelvy, Botox, Qulipta |
| Abbott Laboratories | $265.00 | 2019-2025 | Proclaim |
| Vertiflex, INC. | $258.02 | 2019 | |
| Boston Scientific Corporation | $252.70 | 2019-2024 | Infinion 16 |
| Allergan, INC. | $179.57 | 2019-2022 | |
| Nevro Corp. | $137.24 | 2019-2024 | Senza |
| Teva Pharmaceuticals USA, INC. | $124.26 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $120.59 | 2019 | |
| Collegium Pharmaceutical, INC. | $96.04 | 2019-2022 | |
| Lilly USA, LLC | $83.82 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $83.43 | 2020-2021 | |
| Pfizer INC. | $76.82 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $71.29 | 2019-2020 | |
| Lundbeck LLC | $56.85 | 2023 | Vyepti |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $53.13 | 2023-2024 | Mild Device Kit |
| Amgen INC. | $51.77 | 2019-2021 | |
| Daiichi Sankyo INC. | $50.57 | 2019 | |
| Teleflex LLC | $47.06 | 2024-2025 | Arrow |
| Avanos Medical | $46.57 | 2019 | |
| Fidia Pharma USA INC. | $45.48 | 2021-2024 | Hymovis |
| Painteq LLC | $40.22 | 2023-2024 | Painteq |
| Averitas Pharma INC. | $39.70 | 2023-2024 | Qutenza |
| Globus Medical, INC. | $33.32 | 2025 | Senza |
| Sentynl Therapeutics, INC. | $29.28 | 2019 | |
| Tersera Therapeutics LLC | $28.77 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.41 | 2022 | |
| Janssen Biotech, INC. | $20.97 | 2025 | Tremfya |
| Stimwave Technologies Incorporated | $20.03 | 2020 | |
| Haemonetics Corporation | $17.56 | 2025 | Teg6s Hemostasis System |
| Pacira Pharmaceuticals Incorporated | $16.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Camp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.